ProAxsis
Latest round
- Seed
Last raised
- Feb 2014
Total raised
- $0.3M
Investors
- 2
About ProAxsis
Based in Belfast, UK, and co-founded by Brian Walker and Lorraine Martin in 2013, ProAxsis Ltd operates as a diagnostic company offering diagnostic assay kits for the measurement of active protease biomarkers of disease. ProAxsis develops and supplies diagnostic tests that detect active protease biomarkers, offering a crucial opportunity for early intervention in diseases such as Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF), Bronchiectasis, and Alpha-1 Anti-trypsin Deficiency (A1ATD), by utilizing its ProteaseTag® Technology. ProAxsis' assays, based on its patented ProteaseTag® molecules, enable rapid and specific detection of protease activity, paving the way for personalized treatment strategies and improved patient outcomes. Their product range includes NEATstik®, ProteaseTag® Active Neutrophil Elastase Immunoassay, ProteaseTag® Active Proteinase 3 Immunoassay, and K-Postn Immunoassay. Additionally, the firm also offers a range of clinical support and R&D services, including clinical trial support, assay development, and customized research projects.
Who invested in ProAxsis
2 investors across 1 round
See all investors in ProAxsis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 23, 2014
Amount
$0.3M
Investors
Questions about ProAxsis
Who invested in ProAxsis?
ProAxsis has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ProAxsis raised?
ProAxsis has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ProAxsis last raise money?
ProAxsis's most recent round on record is a Seed, in Feb 2014.
What does ProAxsis do?
Based in Belfast, UK, and co-founded by Brian Walker and Lorraine Martin in 2013, ProAxsis Ltd operates as a diagnostic company offering diagnostic assay kits for the measurement of active protease biomarkers of disease.
Where is ProAxsis headquartered?
ProAxsis is headquartered in Belfast, UK.
Which VCs invest in companies like ProAxsis?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at ProAxsis's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like ProAxsis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.